New saquinavir formulation enters clinical trials.
Torres
G
G
D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007546:Isoquinolines / Q000008:administration & dosage / Q000627:therapeutic use*; D018579:Patient Selection; D010919:Placebos; D011804:Quinolines / Q000008:administration & dosage / Q000627:therapeutic use*; D019258:Saquinavir
D017320:HIV Protease Inhibitors; D007546:Isoquinolines; D010919:Placebos; D011804:Quinolines; D019258:Saquinavir